Familial restrictive cardiomyopathy
MONDO:0016340An instance of restrictive cardiomyopathy that is caused by an inherited modification of the individual's genome.
Also known as: hereditary restrictive cardiomyopathy
70 clinical trials for this condition and its sub-types, 0 tagged with Familial restrictive cardiomyopathy itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Familial restrictive cardiomyopathy
-
Glycogen storage disease II 31 trials · 41 incl. sub-types
-
Gaucher disease type I 12 trials
-
ATTRV122I amyloidosis 7 trials
-
Atrial standstill 1 trial
2 sub-types
- Atrial standstill 1 0 trials
- Atrial standstill 2 0 trials
-
1 sub-type
-
Dilated cardiomyopathy 1KK 0 trials
-
Pompe disease drug trial halted after just 3 patients
Disease control Stopped earlyThis study tested an oral drug called duvoglustat in adults with Pompe disease, a rare genetic disorder that causes muscle weakness. Only 3 people took part, and the study was stopped early. Researchers looked at safety and whether the drug could improve walking distance and othe…
Phase 2 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 16:43 UTC
-
Hidden heart condition: study seeks to uncover missed diagnosis in heart failure patients
Knowledge-focused Stopped earlyThis study aims to find out how common transthyretin amyloidosis cardiomyopathy (ATTR-CM) is in Russian patients with a certain type of heart failure. Researchers will review medical records and then invite some patients for extra heart tests to confirm or rule out ATTR-CM. The g…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:47 UTC